ALKS vs TFC · P/E 14, rev $1.56B vs rev $24.54B
Alkermes Plc (ALKS) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
TFC (TFC) common stock.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. TFC currently screens at market cap $0.
Not investment advice. Open the ALKS and TFC stock pages for the full models.
Not investment advice.